All terms in EFO
| Label | Id | Description |
|---|---|---|
| kidney injury molecule 1 measurement | EFO_0010917 | [Quantification of the amount of kidney injury molecule 1 in a sample] |
| Intimal Sarcoma | EFO_1000305 | [A malignant neoplasm arising from the large blood vessels. It is characterized by the presence of tumor cells that grow within the lumen of the blood vessels. The intraluminal tumor growth may result in vascular obstruction and spread of tumor emboli to peripheral organs. The prognosis is usually poor.] |
| spindle cell sarcoma | MONDO_0002927 | [A malignant mesenchymal neoplasm composed of spindle-shaped cells. This is a morphologic term which can be applied to a wide range of sarcomas.] |
| lectin-like oxidized LDL receptor 1 measurement | EFO_0010918 | [Quantification of the amount of lectin-like oxidized LDL receptor 1 in a sample] |
| heat shock 27 kDa protein measurement | EFO_0010915 | [Quantification of the amount of heat shock 27 kDa protein in a sample] |
| interleukin-27 measurement | EFO_0010916 | [Quantification of the amount of interleukin-27 in a sample] |
| eosinophil cationic protein measurement | EFO_0010913 | [Quantification of the amount of eosinophil cationic protein in a sample] |
| fatty acid-binding protein, adipocyte measurement | EFO_0010914 | [Quantification of the amount of fatty acid-binding protein, adipocyte in a sample] |
| C-X-C motif chemokine 16 measurement | EFO_0010911 | [Quantification of the amount of C-X-C motif chemokine 16 in a sample] |
| endothelial cell-specific molecule 1 measurement | EFO_0010912 | [Quantification of the amount of endothelial cell-specific molecule 1 in a sample] |
| C-C motif chemokine 20 measurement | EFO_0010910 | [Quantification of the amount of C-C motif chemokine 20 in a sample] |
| Calcium channel blocker use measurement | EFO_0009930 | [Quantification of some aspect of the use of calcium channel blockers.] |
| Agents acting on the renin-angiotensin system use measurement | EFO_0009931 | [Quantification of some aspect of the use of agents acting on the renin-angiotensin system.] |
| HMG CoA reductase inhibitor use measurement | EFO_0009932 | [Quantification of some aspect of the use of HMG CoA reductase inhibitors.] |
| obsolete_postaxial polydactyly type A, unilateral | Orphanet_295163 | |
| obsolete_polysyndactyly, bilateral | Orphanet_295161 | |
| Kidney Cyst | EFO_1000313 | [Abnormal fluid filled sac within the kidney, either acquired or congenital.] |
| Opioid use measurement | EFO_0009937 | [Quantification of some aspect of the use of opioid drugs.] |
| Kidney Medullary Carcinoma | EFO_1000314 | [A type of renal carcinoma affecting mostly young African-Americans. It is located in the medulla of the kidney, and follows an aggressive clinical course. Most reported cases have shown metastatic disease at the time of diagnosis.] |
| obsolete_neuroectodermal melanolysosomal disease | Orphanet_33445 |